| Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension R Paulin, J Meloche, MH Jacob, M Bisserier, A Courboulin, S Bonnet American Journal of Physiology-Heart and Circulatory Physiology 301 (5 …, 2011 | 161 | 2011 |
| Krüppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension A Courboulin, VL Tremblay, M Barrier, J Meloche, MH Jacob, ... Respiratory research 12, 1-10, 2011 | 132 | 2011 |
| Identification of a tetrahydroquinoline analog as a pharmacological inhibitor of the cAMP-binding protein Epac D Courilleau, M Bisserier, JC Jullian, A Lucas, P Bouyssou, ... Journal of Biological Chemistry 287 (53), 44192-44202, 2012 | 126 | 2012 |
| Mechanisms of resistance to EZH2 inhibitors in diffuse large B-cell lymphomas M Bisserier, N Wajapeyee Blood, The Journal of the American Society of Hematology 131 (19), 2125-2137, 2018 | 120 | 2018 |
| Critical role for the advanced glycation end‐products receptor in pulmonary arterial hypertension etiology J Meloche, A Courchesne, M Barrier, S Carter, M Bisserier, R Paulin, ... Journal of the American Heart Association 2 (1), e005157, 2013 | 111 | 2013 |
| Multifunctional mitochondrial Epac1 controls myocardial cell death L Fazal, M Laudette, S Paula-Gomes, S Pons, C Conte, F Tortosa, ... Circulation research 120 (4), 645-657, 2017 | 99 | 2017 |
| Exchange protein directly activated by cAMP 1 promotes autophagy during cardiomyocyte hypertrophy AC Laurent, M Bisserier, A Lucas, F Tortosa, M Roumieux, A De Regibus, ... Cardiovascular research 105 (1), 55-64, 2015 | 80 | 2015 |
| RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes J Meloche, R Paulin, A Courboulin, C Lambert, M Barrier, P Bonnet, ... Arteriosclerosis, thrombosis, and vascular biology 31 (9), 2114-2124, 2011 | 77 | 2011 |
| Current and emerging therapeutic approaches to pulmonary hypertension M Bisserier, N Pradhan, L Hadri Reviews in cardiovascular medicine 21 (2), 163, 2020 | 64 | 2020 |
| Carabin Protects Against Cardiac Hypertrophy by Blocking Calcineurin, Ras, and Ca2+/Calmodulin-Dependent Protein Kinase II Signaling M Bisserier, M Berthouze-Duquesnes, M Breckler, F Tortosa, L Fazal, ... Circulation 131 (4), 390-400, 2015 | 51 | 2015 |
| Regulation of the methylation and expression levels of the BMPR2 gene by SIN3a as a novel therapeutic mechanism in pulmonary arterial hypertension M Bisserier, P Mathiyalagan, S Zhang, F Elmastour, P Dorfmüller, ... Circulation 144 (1), 52-73, 2021 | 42 | 2021 |
| Comorbidities, sequelae, blood biomarkers and their associated clinical outcomes in the Mount Sinai Health System COVID-19 patients A Brojakowska, A Eskandari, M Bisserier, J Bander, VNS Garikipati, ... PLoS One 16 (7), e0253660, 2021 | 29 | 2021 |
| Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension disease M Bisserier, R Janostiak, F Lezoualc’h, L Hadri Vascular Biology 2 (1), R17-R34, 2020 | 27 | 2020 |
| Interferon alpha-inducible protein 6 regulates NRASQ61K-induced melanomagenesis and growth R Gupta, M Forloni, M Bisserier, SK Dogra, Q Yang, N Wajapeyee Elife 5, e16432, 2016 | 27 | 2016 |
| Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension B Strauss, Y Sassi, C Bueno-Beti, Z Ilkan, N Raad, M Cacheux, ... Journal of molecular and cellular cardiology 127, 20-30, 2019 | 26 | 2019 |
| AAV1. SERCA2a gene therapy reverses pulmonary fibrosis by blocking the STAT3/FOXM1 pathway and promoting the SNON/SKI axis M Bisserier, J Milara, Y Abdeldjebbar, S Gubara, C Jones, C Bueno-Beti, ... Molecular Therapy 28 (2), 394-410, 2020 | 24 | 2020 |
| Cell‐Free mitochondrial DNA as a potential biomarker for astronauts' health M Bisserier, S Shanmughapriya, AK Rai, C Gonzalez, A Brojakowska, ... Journal of the American Heart Association 10 (21), e022055, 2021 | 22 | 2021 |
| Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19 W Hamouche, M Bisserier, A Brojakowska, A Eskandari, K Fish, ... Journal of Molecular and Cellular Cardiology 153, 72-85, 2021 | 22 | 2021 |
| Large extracellular vesicle-associated Rap1 accumulates in atherosclerotic plaques, correlates with vascular risks and is involved in atherosclerosis L Perdomo, X Vidal-Gomez, R Soleti, L Vergori, L Duluc, M Chwastyniak, ... Circulation research 127 (6), 747-760, 2020 | 20 | 2020 |
| A novel secreted-cAMP pathway inhibits pulmonary hypertension via a feed-forward mechanism C Jones, M Bisserier, C Bueno-Beti, G Bonnet, S Neves-Zaph, SY Lee, ... Cardiovascular Research 116 (8), 1500-1513, 2020 | 20 | 2020 |
